(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Marathon, Kopin Corporation, and Karyopharm Therapeutics.

The three biggest losers today are Ebix, Marine Petroleum Trust, and NetEase.

Winners today

1. Marathon (MARA) – 11.38%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon jumping 11.38% to $30.03 on Wednesday while NASDAQ rose 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-3.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be oversold (<=20).

Volatility

Marathon’s last week, last month’s, and last quarter’s current intraday variation average was 9.96%, 4.74%, and 5.21%.

Marathon’s highest amplitude of average volatility was 9.96% (last week), 6.67% (last month), and 5.21% (last quarter).

Yearly Top and Bottom Value

Marathon’s stock is valued at $30.03 at 16:32 EST, above its 52-week high of $27.73.

Previous days news about Marathon

• Marathon (mpc), performance shipping ink time charter deal. According to Zacks on Tuesday, 26 December, "In conclusion, the time charter agreement between Marathon and Performance Shipping is a win-win deal. ", "With the M/T P. Long Beach at its disposal, Marathon gains greater control over its transportation schedules, ensuring timely deliveries and minimizing logistical bottlenecks. "

More news about Marathon.

2. Kopin Corporation (KOPN) – 9.6%

Kopin Corporation, together with its subsidiaries, invents, develops, manufactures, and sells components, subassemblies, and head-worn and hand-held systems in the United States, the Asia-Pacific, Europe, and internationally. It offers miniature active-matrix liquid crystal displays, liquid crystal on silicon displays/spatial light modulators, organic light emitting diode displays, application specific integrated circuits, backlights, and optical lenses; and headset systems. The company's products are used in soldier, avionic, armored vehicle and training, and simulation defense applications; industrial, public safety, and medical headsets; 3D optical inspection systems; and consumer augmented reality and virtual reality wearable headsets systems. Kopin Corporation was incorporated in 1984 and is headquartered in Westborough, Massachusetts.

NASDAQ ended the session with Kopin Corporation jumping 9.6% to $1.94 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Kopin Corporation has a trailing twelve months EPS of $-0.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -60.13%.

More news about Kopin Corporation.

3. Karyopharm Therapeutics (KPTI) – 7.89%

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. The company's lead compound, XPOVIO (selinexor), is approved in the U.S. in various hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. Its NEXPOVIO (selinexor) has also been granted conditional marketing authorization in combination with dexamethasone for adult patients with heavily pretreated multiple myeloma by the European Commission. In addition, the company's SINE compounds also show biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses, and wound-healing. Further, it also has various investigational programs in clinical or preclinical development. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts.

NASDAQ ended the session with Karyopharm Therapeutics rising 7.89% to $0.89 on Wednesday, after three sequential sessions in a row of gains. NASDAQ rose 0.16% to $15,099.18, after three consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Karyopharm Therapeutics has a trailing twelve months EPS of $-1.31.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Karyopharm Therapeutics’s EBITDA is 0.49.

Sales Growth

Karyopharm Therapeutics’s sales growth is 12.3% for the current quarter and 15.1% for the next.

More news about Karyopharm Therapeutics.

4. MicroStrategy (MSTR) – 7.24%

MicroStrategy Incorporated provides enterprise analytics software and services in the United States, Canada, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy, an enterprise analytics software platform that enables users to create visualizations, customize apps, and embed analytics directly into workflows; and MicroStrategy Cloud Environment, a managed software-as-a-service solution, which offers always-on threat monitoring and enables rapid analytics development and deployment to deliver security and data privacy requirements. The company also provides MicroStrategy Support that helps customers to achieve their system availability and uptime goals, and to improve the overall experience through highly responsive troubleshooting and proactive technical product support. In addition, it offers MicroStrategy Consulting, which offers customers with architecture and implementation services to help them quickly realize results, as well as helps to achieve returns on investment derived from understanding of data; and MicroStrategy Education that provides free and paid learning options, as well as holds and acquires bitcoin. The company offers its services through enterprise sales force and channel partners. It serves companies from a range of industries, including banking, technology, consulting, manufacturing, insurance, healthcare, and telecommunications, as well as the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.

NASDAQ ended the session with MicroStrategy jumping 7.24% to $647.60 on Wednesday while NASDAQ rose 0.16% to $15,099.18.

Earnings Per Share

As for profitability, MicroStrategy has a trailing twelve months EPS of $2.05.

PE Ratio

MicroStrategy has a trailing twelve months price to earnings ratio of 315.9. Meaning, the purchaser of the share is investing $315.9 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.22%.

More news about MicroStrategy.

5. iShares FTSE EPRA/NAREIT Europe (IFEU) – 7.21%

NASDAQ ended the session with iShares FTSE EPRA/NAREIT Europe jumping 7.21% to $35.08 on Wednesday while NASDAQ rose 0.16% to $15,099.18.

Earnings Per Share

As for profitability, iShares FTSE EPRA/NAREIT Europe has a trailing twelve months EPS of $3.47.

More news about iShares FTSE EPRA/NAREIT Europe.

6. Remark Holdings (MARK) – 7.14%

Remark Holdings, Inc. primarily focuses on the development and deployment of artificial-intelligence-based solutions for businesses and software developers. It owns and operates an e-commerce digital media property focuses on a luxury beach lifestyle. The company sells its AI-based products and services under the Remark AI brand in the United States; and under the KanKan brand in China. The company was incorporated in 2006 and is headquartered in Las Vegas, Nevada.

NASDAQ ended the session with Remark Holdings jumping 7.14% to $0.51 on Wednesday, after three successive sessions in a row of gains. NASDAQ rose 0.16% to $15,099.18, after three consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Remark Holdings has a trailing twelve months EPS of $-2.15.

More news about Remark Holdings.

7. Coinbase (COIN) – 7.09%

Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. It offers the primary financial account in the cryptoeconomy for consumers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable developers to build crypto-based applications and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.

NASDAQ ended the session with Coinbase jumping 7.09% to $184.26 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Coinbase has a trailing twelve months EPS of $-3.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.09%.

More news about Coinbase.

8. Liberty TripAdvisor Holdings (LTRPA) – 6.65%

Liberty TripAdvisor Holdings, Inc., through its subsidiaries, operates as an online travel company that connects travelers with travel partners. The company operates through two segments, Hotels, Media & Platform, and Experiences & Dining. Its travel platform provides content, price comparison tools, and online reservation and related services for destinations, accommodations, travel activities and experiences, and restaurants. The company owns and operates a portfolio of travel media brands and businesses, which offers travel-planning and trip-taking resources in the travel industry; and provides click-based, display-based, and subscription-based advertising services. It also operates Viator, a website that offers research, book, and experience activities and attractions in travel destinations; and TheFork, an online restaurant booking platform. Liberty TripAdvisor Holdings, Inc. was founded in 2013 and is headquartered in Englewood, Colorado.

NASDAQ ended the session with Liberty TripAdvisor Holdings rising 6.65% to $0.69 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Liberty TripAdvisor Holdings has a trailing twelve months EPS of $-3.1.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.09%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.1%, now sitting on 1.75B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Liberty TripAdvisor Holdings’s EBITDA is 0.02.

Yearly Top and Bottom Value

Liberty TripAdvisor Holdings’s stock is valued at $0.69 at 16:32 EST, way below its 52-week high of $1.68 and way above its 52-week low of $0.15.

More news about Liberty TripAdvisor Holdings.

9. Kewaunee Scientific Corporation (KEQU) – 6.38%

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company operates in two segments, Domestic and International. Its products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

NASDAQ ended the session with Kewaunee Scientific Corporation rising 6.38% to $27.00 on Wednesday, after two successive sessions in a row of gains. NASDAQ jumped 0.16% to $15,099.18, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Kewaunee Scientific Corporation has a trailing twelve months EPS of $2.39.

PE Ratio

Kewaunee Scientific Corporation has a trailing twelve months price to earnings ratio of 11.3. Meaning, the purchaser of the share is investing $11.3 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.22%.

Moving Average

Kewaunee Scientific Corporation’s value is way higher than its 50-day moving average of $19.40 and way above its 200-day moving average of $16.91.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kewaunee Scientific Corporation’s EBITDA is 0.37.

More news about Kewaunee Scientific Corporation.

10. United Microelectronics (UMC) – 4.87%

United Microelectronics Corporation operates as a semiconductor wafer foundry in Taiwan, Singapore, China, Hong Kong, Japan, the United States, Europe, and internationally. The company provides circuit design, mask tooling, wafer fabrication, and assembly and testing services. It serves fabless design companies and integrated device manufacturers. The company was incorporated in 1980 and is headquartered in Hsinchu City, Taiwan.

NYSE ended the session with United Microelectronics rising 4.87% to $8.61 on Wednesday, after three sequential sessions in a row of gains. NYSE jumped 0.07% to $16,871.70, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, United Microelectronics has a trailing twelve months EPS of $0.9.

PE Ratio

United Microelectronics has a trailing twelve months price to earnings ratio of 9.57. Meaning, the purchaser of the share is investing $9.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.94%.

More news about United Microelectronics.

Losers Today

1. Ebix (EBIX) – -18.13%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia. On December 17, 2023, Ebix, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.

NASDAQ ended the session with Ebix dropping 18.13% to $1.40 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $0.16.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 8.75. Meaning, the purchaser of the share is investing $8.75 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.49%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ebix’s stock is considered to be overbought (>=80).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Dec 1, 2022, the estimated forward annual dividend rate is 0.3 and the estimated forward annual dividend yield is 6.94%.

More news about Ebix.

2. Marine Petroleum Trust (MARPS) – -5.66%

Marine Petroleum Trust, together with its subsidiary, Marine Petroleum Corporation, operates as a royalty trust in the United States. As of June 30, 2020, it had an overriding royalty interest in 59 oil and natural gas leases covering an aggregate of 217,056 gross acres located in the Central and Western areas of the Gulf of Mexico off the coasts of Louisiana and Texas. The company was founded in 1956 and is based in Dallas, Texas.

NASDAQ ended the session with Marine Petroleum Trust dropping 5.66% to $4.04 on Wednesday, after three sequential sessions in a row of losses. NASDAQ rose 0.16% to $15,099.18, after three sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Marine Petroleum Trust has a trailing twelve months EPS of $0.54.

PE Ratio

Marine Petroleum Trust has a trailing twelve months price to earnings ratio of 7.48. Meaning, the purchaser of the share is investing $7.48 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 102.21%.

Yearly Top and Bottom Value

Marine Petroleum Trust’s stock is valued at $4.04 at 16:32 EST, way under its 52-week high of $8.87 and above its 52-week low of $4.04.

More news about Marine Petroleum Trust.

3. NetEase (NTES) – -4.93%

NetEase, Inc. engages in online games, music streaming, online intelligent learning services, and internet content services businesses in China and internationally . The company operates through Games and Related Value-Added Services, Youdao, Cloud Music, and Innovative Businesses and Others segments. It develops and operates PC and mobile games, as well as offers games licensed from other game developers. The company's products and services include Youdao Dictionary, an online knowledge tool; Youdao Translation, a tool specifically designed to support translation needs of business and leisure travelers; U-Dictionary, an online dictionary and translation app; Youdao Kids' Dictionary, a smart and fun tool; smart devices, such as Youdao Dictionary Pen, Youdao Smart Learning Pad, Youdao Listening Pod, Youdao Smart Light, Youdao Pocket Translator, and Youdao Super Dictionary; online courses; interactive learning apps; and education digitalization solutions, such as Youdao Smart Learning Terminal, a device that automates paper-based homework processing; Youdao Smart Cloud, a cloud-based platform that allows third-party app developers, smart device brands, and manufacturers to the company's OCR capabilities; and Youdao Sports, a sports-centric educational system. Its products and services also include NetEase Cloud Music, a music streaming platform; Yanxuan, an e-commerce platform, which sells private label products; www.163.com portal and related mobile app, Wangyi Xinwen, which deliver information such as news, sports events, technology, fashion trends, and online entertainment; NetEase Mail, an email service; NetEase CC Live streaming, a live streaming platform with a focus on game broadcasting; and NetEase Pay, a payment platform. The company was formerly known as NetEase.com, Inc. and changed its name to NetEase, Inc. in March 2012. NetEase, Inc. was founded in 1997 and is headquartered in Hangzhou, the People's Republic of China.

NASDAQ ended the session with NetEase sliding 4.93% to $87.65 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, NetEase has a trailing twelve months EPS of $5.79.

PE Ratio

NetEase has a trailing twelve months price to earnings ratio of 15.14. Meaning, the purchaser of the share is investing $15.14 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.68%.

More news about NetEase.

4. Canopy Growth (CGC) – -4.51%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth dropping 4.51% to $5.41 on Wednesday, after four successive sessions in a row of gains. NASDAQ jumped 0.16% to $15,099.18, after three successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.88.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.66%.

Volume

Today’s last reported volume for Canopy Growth is 2748700 which is 8.65% below its average volume of 3009000.

Revenue Growth

Year-on-year quarterly revenue growth declined by 20.9%, now sitting on 368.59M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canopy Growth’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 90.6% and 96.3%, respectively.

More news about Canopy Growth.

5. Professional Diversity Network (IPDN) – -3.81%

Professional Diversity Network, Inc. operates online professional networking communities with career resources in the United States. It operates in two segments, Professional Diversity Network (PDN Network) and National Association of Professional Women (NAPW Network). The company offers recruitment services, such as single and multiple job postings, recruitment media, talent recruitment communities, corporate memberships, hiring campaign marketing and advertising, e-newsletter marketing, and research and outreach services to various cultural groups and employers. It also provides consumer advertising and consumer marketing solutions through advertising and job postings on its Websites. In addition, the company operates a women-only professional networking organization. Professional Diversity Network, Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Professional Diversity Network falling 3.81% to $2.02 on Wednesday while NASDAQ rose 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Professional Diversity Network has a trailing twelve months EPS of $-0.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -204.07%.

Yearly Top and Bottom Value

Professional Diversity Network’s stock is valued at $2.02 at 16:32 EST, way below its 52-week high of $7.77 and way higher than its 52-week low of $1.15.

Moving Average

Professional Diversity Network’s worth is way higher than its 50-day moving average of $1.82 and way below its 200-day moving average of $2.98.

Revenue Growth

Year-on-year quarterly revenue growth declined by 5%, now sitting on 7.76M for the twelve trailing months.

Volume

Today’s last reported volume for Professional Diversity Network is 112375 which is 56.79% above its average volume of 71668.

More news about Professional Diversity Network.

6. Maiden Holdings, Ltd. (MHLD) – -3.7%

Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty reinsurance solutions to regional and specialty insurers in Europe, the United States, and internationally. It operates in two segments: Diversified Reinsurance and AmTrust Reinsurance. The company writes treaties on a quota share basis and excess of loss basis. It also offers auto and credit life insurance products through its insurer partners to retail clients; and a range of legacy services to small insurance companies. The company was founded in 2007 and is headquartered in Pembroke, Bermuda.

NASDAQ ended the session with Maiden Holdings, Ltd. falling 3.7% to $2.34 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Maiden Holdings, Ltd. has a trailing twelve months EPS of $0.23.

PE Ratio

Maiden Holdings, Ltd. has a trailing twelve months price to earnings ratio of 10.17. Meaning, the purchaser of the share is investing $10.17 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.29%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Maiden Holdings, Ltd.’s EBITDA is 7.77.

Moving Average

Maiden Holdings, Ltd.’s worth is way above its 50-day moving average of $1.88 and way above its 200-day moving average of $1.96.

Sales Growth

Maiden Holdings, Ltd.’s sales growth is 119.9% for the current quarter and 179.6% for the next.

Volume

Today’s last reported volume for Maiden Holdings, Ltd. is 53171 which is 63.58% below its average volume of 146030.

More news about Maiden Holdings, Ltd..

7. FibroGen (FGEN) – -3.68%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen falling 3.68% to $0.77 on Wednesday, after three consecutive sessions in a row of gains. NASDAQ rose 0.16% to $15,099.18, after three successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.06.

Yearly Top and Bottom Value

FibroGen’s stock is valued at $0.77 at 16:32 EST, way below its 52-week high of $25.69 and way above its 52-week low of $0.33.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 37.1% and 46.9%, respectively.

Sales Growth

FibroGen’s sales growth is 5.3% for the present quarter and 16.4% for the next.

Moving Average

FibroGen’s worth is way above its 50-day moving average of $0.56 and way under its 200-day moving average of $7.34.

More news about FibroGen.

8. Live Ventures Incorporated (LIVE) – -3.55%

Live Ventures Incorporated, together with its subsidiaries, engages in the flooring manufacturing, steel manufacturing, and retail businesses in the United States. The company's Flooring Manufacturing segment manufactures and sells carpets and rugs, and yarn products focusing on the residential, niche commercial, and hospitality end-markets; and resells hard surface flooring products. This segment serves flooring dealers, home centers, and other flooring manufacturers, as well as directly to end users. Its Steel Manufacturing segment manufactures and sells pre-finished de-carb free tool and die steel products, such as deluxe alloy plates, deluxe tool steel plates, precision ground flat stock products, and drill rods. This segment serves steel distributors and steel service centers. The company's Retail segment operates 62 specialty entertainment retail storefronts that offer entertainment products, including new and pre-owned movies, video games, and music products, as well as ancillary products, such as books, comics, toys, and collectibles. It buys, sells, and trades in new and pre-owned movies, music, video games, electronics, and collectibles through 35 Vintage Stock, 3 V-Stock, 13 Movie Trading company, and 11 EntertainMart retail locations in Missouri, Texas, Oklahoma, Kansas, Arkansas, Utah, Colorado, Illinois, Idaho, and New Mexico, as well as sells new and used movies, video games, music, and toys through Website, vintagestock.com. This segment also offers services to customers, such as rentals, special orders, disc and video game hardware repair services, and other services. Its Corporate and Other segment provides directory listing services. The company was formerly known as LiveDeal, Inc. and changed its name to Live Ventures Incorporated in October 2015. Live Ventures Incorporated was founded in 1968 and is based in Las Vegas, Nevada.

NASDAQ ended the session with Live Ventures Incorporated sliding 3.55% to $25.00 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Live Ventures Incorporated has a trailing twelve months EPS of $-0.03.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.1%.

More news about Live Ventures Incorporated.

9. MEI Pharma (MEIP) – -3.07%

MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase II clinical trial for the treatment of patients with relapsed/refractory follicular lymphoma, as well as in Phase Ib multi-arm trial to treat B-cell malignancies; and Voruciclib, an oral cyclin-dependent kinase inhibitor, which is in Phase Ib clinical trial for acute myeloid leukemia and B-cell malignancies. It also develops ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex that is in Phase I clinical trial for the treatment of human epidermal growth factor receptor 2 negative breast cancer; and Pracinostat, an oral available histone deacetylase inhibitor, which is in Phase II clinical trial to treat patients with myelodysplastic syndrome. The company has a license, development, and commercialization agreement with Kyowa Kirin Company; a clinical collaboration with BeiGene, Ltd.; a license, development, manufacturing, and commercialization agreement with Helsinn Healthcare SA; and license agreements with Presage Biosciences, Inc. and CyDex Pharmaceuticals, Inc. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was founded in 2000 and is headquartered in San Diego, California.

NASDAQ ended the session with MEI Pharma falling 3.07% to $6.00 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.16% to $15,099.18, after three successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, MEI Pharma has a trailing twelve months EPS of $6.17.

PE Ratio

MEI Pharma has a trailing twelve months price to earnings ratio of 0.97. Meaning, the purchaser of the share is investing $0.97 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 69.37%.

Moving Average

MEI Pharma’s worth is below its 50-day moving average of $6.66 and under its 200-day moving average of $6.41.

Earnings Before Interest, Taxes, Depreciation, and Amortization

MEI Pharma’s EBITDA is -0.27.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 182.5% and positive 42.2% for the next.

More news about MEI Pharma.

10. Rumble (RUM) – -3.05%

Rumble Inc. operates video sharing platforms in the United States, Canada, and internationally. The company operates rumble.com, a platform where users can subscribe to channels to stay in touch with creators, and access video on-demand (VOD) and live content streamed by creators. It also operates locals.com, a subscription platform for creators and subscribers to engage through VOD, podcasts, live chat, polls, and community discussions; and Rumble Advertising Center (RAC), an online advertising management exchange. The company was founded in 2013 and is headquartered in Longboat Key, Florida.

NASDAQ ended the session with Rumble sliding 3.05% to $4.85 on Wednesday while NASDAQ jumped 0.16% to $15,099.18.

Earnings Per Share

As for profitability, Rumble has a trailing twelve months EPS of $-0.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.68%.

More news about Rumble.

Stay up to date with our winners and losers daily report